ARDS - Aridis Pharmaceuticals EPS beats by $0.27 beats on revenue August, 11 2020 04:26 PM Aridis Pharmaceuticals Inc. Aridis Pharmaceuticals (NASDAQ:ARDS): Q2 GAAP EPS of -$0.47 beats by $0.27.More news on: Aridis Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...